Critical IllnessNCT04143503
Observational Cohort Study on the Use of Parenteral Nutrition and Clinical Outcomes in Adult Critically Ill Patients
An observational study of Critical Illness, run by Fresenius Kabi at 76 sites in 11 countries.
Trial summary
The aim of this study is to characterise the use of clinical nutrition support, especially of parenteral nutrition that is administered directly into a vein, in adult patients with critical illness. Read more about this study
- Who is it for?
- Ages 18 to 95 years
- Conditions the study is for
- Critical Illness
- How many people
- 1,208 participants
- Where
- 76 sitesin 11 countries
- Study dates
- 5 Nov 2019to 30 Jul 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 95 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population will include adult male and female patients with critical illness (i.e. patients requiring pharmacological and/or technical support to treat a vital threat) who are hospitalised in a medical, surgical, or trauma ICU for at least 5 consecutive calendar days.
Who may be able to join
- Age ≥18 years and ≤95 years, male or female
- Hospitalised in a medical, surgical, or trauma ICU for at least five consecutive calendar days and either admitted to the ICU during the predefined screening month or admitted to the ICU maximally 4 days before start of the screening month
- BMI ≥18.5 kg/m2 and ≤45 kg/m2
- Written informed consent or requirements of local/national ethical committee
Who cannot join
- Burn injury
- Pre-existing neuromuscular or psychiatric disorders that preclude proper assessment of functional status
- Severe hypoxic brain injury or severe neurological diagnosis (e.g. meningitis, encephalitis, brain trauma, spinal cord injury) at the time of ICU admission that precludes proper assessment of functional status
- Receiving home parenteral nutrition at the time of ICU admission (e.g. due to short bowel syndrome)
- Receiving home enteral nutrition (tube feeding) at the time of ICU admission
- Chronic invasive or chronic non-invasive ventilatory support before ICU admission
Show all 10Show fewer
- Patients with a legal representative in place before ICU admission
- Admission to the ICU for palliative care
- Previous participation in this study (if the screening month is repeated and a patient is re-admitted to the ICU during the repeated screening month, only ICU data collected for that patient during the original screening month will be included)
- Concurrent enrolment in a nutrition-related interventional study at the time of screening
Trial locations and contacts
76 sites in 11 countries.
76 sites in 11 countries
Czechia13 sites
Clinic of Anesthesiology, Resuscitation and Intensive Care, University Hospital Brno
Brno, 62500
Clinic of Internal Medicine and Gastroenterology, University Hospital Brno
Brno, 62500
St Anne's University Hospital Brno
Brno, 65691
3rd Department of Internal Medicine - Metabolic Care and Gerontology, University Hospital Hradec Králové
Hradec Králové, 50005
Clinic of Anesthesiology, Resuscitation and Intensive Care, University Hospital Hradec Králové
Hradec Králové, 50005
III Internal Gerontometabolic Clinic, University Hospital Hradec Králové
Hradec Králové, 50005
University Hospital Olomouc Palacky University in Olomouc Faculty of Medicine and Dentistry
Olomouc, 77900
Hospital Pardubice Region, Inc.
Pardubice, 53003
Charles University Hospital Plzen
Pilsen, 30460
University Hospital Pilsen University Hospital in Pilsen (Fakultní nemocnice Plzeň: Úvodní strana)
Pilsen, 30460
General University Hospital Prague
Prague, 12808
Motol University Hospital
Prague, 15006
Masaryk Hospital
Ústí nad Labem, 40011
France13 sites
Centre Hospitalier Universitaire d'Angers
Angers, 49100
Centre Hospitalier Régional Universitaire de Besançon
Besançon, 25000
Hôpital de la Cavale Blanche à Brest
Brest, 29200
Hospital Center University of Caen Normandie
Caen, 14000
Hôpital Trousseau - Surgical Intensive Care Unit
Chambray-lès-Tours, 37170
Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, 63000
Centre Hospitalier Universitaire de Grenoble - Hôpital Michallon
La Tronche, 38700
Hospices Civils de Lyon - Hópital Edouard Herriot
Lyon, 69003
Institut Paoli-Calmettes
Marseille, 13009
Centre Hospitalier Universitaire de Saint-Étienne - Hopital Nord
Saint-Etienne, 42000
Hôpital Foch
Suresnes, 92150
Centre Hospitalier de Valenciennes
Valenciennes, 59300
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois
Vandœuvre-lès-Nancy, 54500
Spain10 sites
Hospital Universitari de Bellvitge
Barcelona, 08907
Hospital Universitario de Burgos
Burgos, 09006
Hospital Universitario Dr Josep Trueta de Girona - Intensive Care Unit
Girona, 17007
Hospital Universitari Arnau de Vilanova
Lleida, 25198
Hospital Universitario Infanta Leonor
Madrid, 28031
Hospital Universitario de Fuenlabrada - Intensive Care Unit
Madrid, 28942
Hospital Universitari Son Espases
Palma de Mallorca, 07120
Hospital Clinic de Valencia
Valencia, 46010
Hospital Universitario Rio Hortega
Valladolid, 47012
Hospital Alvaro Cunqueiro
Vigo, 36312
Belgium9 sites
Vivalia - Clinique Saint Joseph
Arlon, 6700
Hospital Erasme
Brussels, 1070
Universitair Ziekenhuis Brussel
Brussels, 1090
Clinique Universitaire Saint-Luc - Université Catholique de Louvain (UCL)
Brussels, 1200
Grand Hôpital de Charleroi
Charleroi, 6000
University Hospital Antwerp
Edegem, 2650
Ghent University Hospital
Ghent, 9000
Saint-Pierre Clinic
Ottignies, 1340
Hospital Center of Wallonie Picarde
Tournai, 7500
Germany9 sites
Charité Universitätsmedizin - Campus Benjamin Franklin
Berlin, 12203
Charité Universitatsmedizin - Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin
Berlin, 13353
Augusta Kliniken Bochum Hattingen
Bochum, 44791
KRH Klinikum Siloah - Klinik für Gastroenterologie, Interventionelle Endoskopie und Diabetologie
Hanover, 30459
UKSH Universitätsklinikum Schleswig-Holstein - Campus Kiel
Kiel, 24105
Klinikum St. Georg
Leipzig, 04129
Klinikum der Universität München
Munich, 81377
Robert-Bosch-Krankenhaus
Stuttgart, 70376
Klinikum Wetzlar-Braunfels - Klinik für Geriatrie
Wetzlar, 35578
Hungary6 sites
Dél-Pesti Centrumkórház - National Institute of Hematology and Infectiology
Budapest, 1096
MH EK Honvédkorház
Budapest, 1134
University of Debrecen - Department of Anaesthesiology and Intensive Therapy
Debrecen, 4032
Jósa András Oktatókórház
Nyíregyháza, 4400
Fejér Megyei Szent György Egyetemi Oktató Kórház
Székesfehérvár, 8000
Csolnoky Ferenc Kórház
Veszprém, 8200
Poland6 sites
Uniwersytecki Szpital Kliniczny w Białymstoku
Bialystok, 15-276
10 Wojskowy Szpital Kliniczny z Polikliniką w Bydgoszczy
Bydgoszcz, 85-001
Medical University of Silesia
Katowice, 40-055
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie sp. Z o.o.
Krakow, 31-826
Uniwersytecki Szpital Kliniczny w Opolu
Opole, 45-401
Szpital Wojewódzki w Poznaniu
Poznan, 60-479
Italy5 sites
Ospedali Riuniti di Foggia
Foggia, 71121
Ospedale San Paolo
Milan, 20142
Ospedale Umberto I
Nocera Inferiore, 84014
Hospital Santa Maria delle Croci
Ravenna, 48121
Ospedale Infermi Rimini
Rimini, 47900
United Kingdom3 sites
Liverpool Heart and Chest Hospital
Liverpool, L14 3PE
The Royal Liverpool University Hospital
Liverpool, L7 8XP
The Royal London Hospital, Barts Health NHS Trust & Queen Mary University of London
London, E1 1BB
Sweden1 site
Karolinska University Hospital, PMI Huddinge, B31
Stockholm, 14186
About this study
Official title: Observational Cohort Study to Characterise the Current Use of Parenteral Nutrition and Clinical Outcomes in Adult Critically Ill Patients Hospitalised in Intensive Care Units in Europe
The aim of this study is to characterise the use of clinical nutrition support, especially of parenteral nutrition that is administered directly into a vein, in adult patients with critical illness. The study wants to assess nutritional balance (that means the ratio of calories and protein prescribed to calories and protein actually received). Furthermore, it wants to evaluate whether the nutrition received has influence on the patients' clinical outcome, with focus on measures of physical function, such as capability of conducting daily living activities. As the study is "observational", no specific medications or treatments will be provided as part of the study to the patients.
Study patients will be observed during their stay on an intensive care unit, for a maximum duration of 15 days. Furthermore, questions on the well-being of the patients will be asked via telephone interviews 30 and 90 days after their admission to the intensive care unit.
Data of approximately 1250 patients will be collected and evaluated in this study, from approximately 100 hospitals in 11 European countries (Austria, Belgium, Czech Republic, France, Germany, Hungary, Italy, Poland, Spain, Sweden and United Kingdom).
- Conditions
- Critical Illness
- Keywords
- ICU, parenteral nutrition, enteral nutrition, energy intake, protein intake
- Medical subject headings
- Critical Illness, Hyperphagia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| adult critically ill patients | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of patients receiving enteral nutrition (EN), parenteral nutrition (PN), and oral nutrition (ON)/oral nutrition supplements (ONS)
Measured: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Cumulative caloric balance
Measured: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Cumulative protein balance
Measured: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Cumulative calories (kcal/kg and total kcal) administered via EN, PN, ON/ONS, and concomitant medications (e.g. propofol, glucose, citrate, clevidipine), and via all sources combined
Measured: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Cumulative protein (g/kg and total g) administered via EN, PN, ON/ONS, and via all sources combined
Measured: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Proportion of patients with interrupted/stopped or not started clinical nutrition
Measured: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Oct 2019
- Study start5 Nov 2019
- Primary completion13 May 2020
- Study completion30 Jul 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Critical IllnessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,208 participants (actual)
Sponsor and investigators
- Lead sponsor
- Fresenius Kabi
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- IQVIA Commercial GmbH & Co. OHG
- Responsible party
- Sponsor
- Investigators
- Michael Hiesmayr, Prof. MD, Principal investigator, Medical University of Vienna
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04143503
- Sponsor's protocol ID
- NScr-003-CNI
- Status last verified
- Jul 2020
- First submitted
- 25 Oct 2019
- Last updated
- 31 Jul 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Matejovic M, Huet O, Dams K, Elke G, Vaquerizo Alonso C, Csomos A, Krzych LJ, Tetamo R, Puthucheary Z, Rooyackers O, Tjader I, Kuechenhoff H, Hartl WH, Hiesmayr M. Medical nutrition therapy and clinical outcomes in critically ill adults: a European multinational, prospective observational cohort study (EuroPN). Crit Care. 2022 May 18;26(1):143. doi: 10.1186/s13054-022-03997-z.
PubMed 35585554Hiesmayr M, Csomos A, Dams K, Elke G, Hartl W, Huet O, Krzych LJ, Kuechenhoff H, Matejovic M, Puthucheary ZA, Rooyackers O, Tetamo R, Tjader I, Vaquerizo C. Protocol for a prospective cohort study on the use of clinical nutrition and assessment of long-term clinical and functional outcomes in critically ill adult patients. Clin Nutr ESPEN. 2021 Jun;43:104-110. doi: 10.1016/j.clnesp.2021.01.048. Epub 2021 Feb 12.
PubMed 34024501
Study at a glance
From the registry record, last updated by the sponsor on 31 Jul 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Observational Cohort Study to Characterise the Current Use of Parenteral Nutrition and Clinical Outcomes in Adult Critically Ill Patients Hospitalised in Intensive Care Units in Europe
- ClinicalTrials.gov ID
- NCT04143503
- Acronym / sponsor ID
- NScr-003-CNI
- Conditions
- Critical Illness
- Keywords
- ICU, parenteral nutrition, enteral nutrition, energy intake, protein intake
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,208 participants (actual)
- Lead sponsor
- Fresenius KabiIndustry (pharma, biotech, devices)
- Collaborators
- IQVIA Commercial GmbH & Co. OHG
- Study start
- 5 Nov 2019 (actual)
- Primary completion
- 13 May 2020 (actual)
- Study completion
- 30 Jul 2020 (actual)
- First posted
- 29 Oct 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to characterise the use of clinical nutrition support, especially of parenteral nutrition that is administered directly into a vein, in adult patients with critical illness. The study wants to assess nutritional balance (that means the ratio of calories and protein prescribed to calories and protein actually received). Furthermore, it wants to evaluate whether the nutrition received has influence on the patients' clinical outcome, with focus on measures of physical function, such as capability of conducting daily living activities. As the study is "observational", no specific medications or treatments will be provided as part of the study to the patients.
Study patients will be observed during their stay on an intensive care unit, for a maximum duration of 15 days. Furthermore, questions on the well-being of the patients will be asked via telephone interviews 30 and 90 days after their admission to the intensive care unit.
Data of approximately 1250 patients will be collected and evaluated in this study, from approximately 100 hospitals in 11 European countries (Austria, Belgium, Czech Republic, France, Germany, Hungary, Italy, Poland, Spain, Sweden and United Kingdom).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| adult critically ill patients | – | – |
Who may qualify
- Ages
- 18 to 95 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population will include adult male and female patients with critical illness (i.e. patients requiring pharmacological and/or technical support to treat a vital threat) who are hospitalised in a medical, surgical, or trauma ICU for at least 5 consecutive calendar days.
Key inclusion criteria (4 listed)
- Age ≥18 years and ≤95 years, male or female
- Hospitalised in a medical, surgical, or trauma ICU for at least five consecutive calendar days and either admitted to the ICU during the predefined screening month or admitted to the ICU maximally 4 days before start of the screening month
- BMI ≥18.5 kg/m2 and ≤45 kg/m2
- Written informed consent or requirements of local/national ethical committee
Key exclusion criteria (10 listed)
- Burn injury
- Pre-existing neuromuscular or psychiatric disorders that preclude proper assessment of functional status
- Severe hypoxic brain injury or severe neurological diagnosis (e.g. meningitis, encephalitis, brain trauma, spinal cord injury) at the time of ICU admission that precludes proper assessment of functional status
- Receiving home parenteral nutrition at the time of ICU admission (e.g. due to short bowel syndrome)
- Receiving home enteral nutrition (tube feeding) at the time of ICU admission
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Proportion of patients receiving enteral nutrition (EN), parenteral nutrition (PN), and oral nutrition (ON)/oral nutrition supplements (ONS)
Time frame: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Cumulative caloric balance
Time frame: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Cumulative protein balance
Time frame: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Cumulative calories (kcal/kg and total kcal) administered via EN, PN, ON/ONS, and concomitant medications (e.g. propofol, glucose, citrate, clevidipine), and via all sources combined
Time frame: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Cumulative protein (g/kg and total g) administered via EN, PN, ON/ONS, and via all sources combined
Time frame: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Proportion of patients with interrupted/stopped or not started clinical nutrition
Time frame: from admission to ICU until discharge from ICU or death (maximum of 15 days)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2020.
- Derived from this study: PubMed 35585554Matejovic M, Huet O, Dams K, Elke G, Vaquerizo Alonso C, Csomos A, Krzych LJ, Tetamo R, Puthucheary Z, Rooyackers O, Tjader I, Kuechenhoff H, Hartl WH, Hiesmayr M. Medical nutrition therapy and clinical outcomes in critically ill adults: a European multinational, prospective observational cohort study (EuroPN). Crit Care. 2022 May 18;26(1):143. doi: 10.1186/s13054-022-03997-z.
- Derived from this study: PubMed 34024501Hiesmayr M, Csomos A, Dams K, Elke G, Hartl W, Huet O, Krzych LJ, Kuechenhoff H, Matejovic M, Puthucheary ZA, Rooyackers O, Tetamo R, Tjader I, Vaquerizo C. Protocol for a prospective cohort study on the use of clinical nutrition and assessment of long-term clinical and functional outcomes in critically ill adult patients. Clin Nutr ESPEN. 2021 Jun;43:104-110. doi: 10.1016/j.clnesp.2021.01.048. Epub 2021 Feb 12.
- Individual participant dataSharing planned: No
Related trials for Critical Illness
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Recruiting
Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use
Critically Ill Patients Requiring Mechanical Ventilation
Active, not recruiting
Weighted Blankets for Agitation in Adults in the Intensive Care Unit
Psychomotor Agitation, Critical Illness
Not yet recruitingObservational study
Core Competencies in General Intensive Care Ultrasound (GenIUS): a Delphi Study
Critical Illness, Ultrasound
RecruitingObservational study
Predicting Extubation Failure Using Machine Learning
Extubation Failure, Critical Illness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michael Hiesmayr, Prof. MD principal investigator
Medical University of Vienna
76 sites in 11 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Critical Illness, run by Fresenius Kabi at 76 sites in 11 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 76 sites in Czechia, France, Spain, Belgium, Germany and 6 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of patients receiving enteral nutrition (EN), parenteral nutrition (PN), and oral nutrition (ON)/oral nutrition supplements (ONS) (time frame: from admission to ICU until discharge from ICU or death (maximum of 15 days)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04143503, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2020.